Cross-institution positioning
Sep 4, 2026Reduction leaning. 1 accumulating, 3 reducing, 1 exited across 5 comparable institutions.
Source: Schedule 13 researchTHC Institutional Ownership
TENET HEALTHCARE CORP
Latest stored close $259.83 as of Oct 7, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
40/100
6 tracked · 5 comparable
Latest filing
Sep 4, 2026
Positive breadth
2 positive · 4 negative
Recent close
$259.83
Research confidence
Medium
Institutional Research 22/100 · 1 accumulating · 4 reducing / exited
Ownership history
Reported ownership % history
Latest filing Sep 4, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported1
Reducing / exited
4
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 40/100
Confidence:Medium
Why this signal
- 1 tracked institution accumulating versus 4 reducing/exited.
- 1 tracked institution shows persistent accumulation.
- Latest comparable Form 13F activity is net positive across tracked managers.
- Comparable SEC fundamentals are improving.
Conflicting evidence
- Institutions are reducing while comparable SEC fundamentals are improving.
Institutional
37/100
Insiders
22/100
Fundamentals
66/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 14, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 19 sales by 11 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 22, 20263 non-amendment material events in the last 90 days; 1 capital-related filing/event (0 equity-related, 1 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Jul 29, 2026Revenue +6.8% YoY; Net income +100.2% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 82% through its reported 52-week range; +39.7% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from BlackRock.
Filed Sep 4, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Sep 4, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
T. Rowe Price Associates
Filed Aug 14, 2026
Direction locked
Vanguard Capital Management
Filed Apr 30, 2026
Direction locked
BlackRock
Filed Sep 4, 2026
Direction locked
Vanguard Group
Filed Mar 27, 2026
Direction locked
Invesco
Filed May 9, 2025
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
T. Rowe Price Associates
Filed Aug 14, 2026
Vanguard Capital Management
Filed Apr 30, 2026
BlackRock
Filed Sep 4, 2026
Vanguard Group
Filed Mar 27, 2026
Invesco
Filed May 9, 2025
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales126 reporting owner(s)
90-day purchase breadth0
90-day sale breadth11Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | KERREY J ROBERT | SOpen-market or private sale | Common Stock | 2.5K | $264.62 | Direct | Sep 16, 2026 |
| Sep 14, 2026 | KERREY J ROBERT | SOpen-market or private sale | Common Stock | 4.0K | $264.10 | Direct | Sep 16, 2026 |
| Sep 14, 2026 | KERREY J ROBERT | SOpen-market or private sale | Common Stock | 5.5K | $263.04 | Direct | Sep 16, 2026 |
| Sep 10, 2026 | MARK RICHARD J | SOpen-market or private sale | Common Stock | 10.0K | $263.42 | Direct | Sep 14, 2026 |
| Sep 2, 2026 | West Nadja | SOpen-market or private sale | Common Stock | 1.2K | $258.80 | Direct | Sep 3, 2026 |
| Aug 31, 2026 | Foo Lisa Y | SOpen-market or private sale | Common Stock | 24.0K | $266.32 | Direct | Sep 1, 2026 |
| Aug 28, 2026 | HANEY CECIL D | GGift | Common Stock | 150 | $0.00 | Direct | Aug 31, 2026 |
| Aug 25, 2026 | Sutaria Saumya | SOpen-market or private sale | Common Stock | 7.9K | $275.26 | Direct | Aug 26, 2026 |
| Aug 25, 2026 | Sutaria Saumya | SOpen-market or private sale | Common Stock | 24.9K | $274.10 | Direct | Aug 26, 2026 |
| Aug 25, 2026 | Sutaria Saumya | SOpen-market or private sale | Common Stock | 17.2K | $273.34 | Direct | Aug 26, 2026 |
| Aug 24, 2026 | Sutaria Saumya | SOpen-market or private sale | Common Stock | 36.7K | $278.90 | Direct | Aug 26, 2026 |
| Aug 24, 2026 | Sutaria Saumya | SOpen-market or private sale | Common Stock | 13.3K | $278.17 | Direct | Aug 26, 2026 |
| Aug 24, 2026 | HANEY CECIL D | SOpen-market or private sale | Common Stock | 1.3K | $278.03 | Direct | Aug 26, 2026 |
| Aug 7, 2026 | Romo Tammy | SOpen-market or private sale | Common Stock | 2.5K | $260.83 | Direct | Aug 10, 2026 |
| Aug 6, 2026 | Romo Tammy | SOpen-market or private sale | Common Stock | 4.9K | $264.15 | Direct | Aug 10, 2026 |
| Aug 5, 2026 | Blunt Roy | SOpen-market or private sale | Common Stock | 600 | $262.68 | Direct | Aug 7, 2026 |
| Jul 29, 2026 | Foo Lisa Y | SOpen-market or private sale | Common Stock | 10.0K | $258.03 | Direct | Jul 31, 2026 |
| Jul 27, 2026 | BIERMAN JAMES L | SOpen-market or private sale | Common Stock | 5.0K | $244.96 | Direct | Jul 28, 2026 |
| Jul 27, 2026 | Arbour Paola M | SOpen-market or private sale | Common Stock | 10.9K | $243.90 | Direct | Jul 28, 2026 |
| Jul 27, 2026 | Lynch Christopher S. | SOpen-market or private sale | Common Stock | 3.8K | $243.44 | Direct | Jul 28, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events2
90-day capital-related1
90-day equity-related0
90-day debt-related1
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 22, 2026 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Sep 8, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Jul 23, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 29, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Apr 30, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 10, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 30, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Feb 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Feb 2, 2026 | 8-K | 2.02, 7.01, 8.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Nov 24, 2025 | 8-K | 5.02 | Director or executive change | — | Filing |
| Nov 18, 2025 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Nov 5, 2025 | 8-K | 1.01, 2.03, 9.01 | Material definitive agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$5.6B
Q2 2026
+6.8% YoY 10-Q filed Jul 29, 2026
Operating income
$1.5B
Q2 2026
+82.4% YoY 10-Q filed Jul 29, 2026
Operating margin
26.7%
Q2 2026
+11.1 pts YoY 10-Q filed Jul 29, 2026
Net income
$1.0B
Q2 2026
+100.2% YoY 10-Q filed Jul 29, 2026
Diluted EPS
$9.84
Q2 2026
+213.4% YoY 10-Q filed Jul 29, 2026
Operating cash flow
$2.2B
YTD through Jun 30, 2026
+27.1% YoY 10-Q filed Jul 29, 2026
Free cash flow
$1.9B
YTD through Jun 30, 2026
+35.6% YoY 10-Q filed Jul 29, 2026
Cash & equivalents
$2.2B
As of Jun 30, 2026
-17.3% YoY 10-Q filed Jul 29, 2026
Assets
$30.7B
As of Jun 30, 2026
+6.9% YoY 10-Q filed Jul 29, 2026
Liabilities
$22.0B
As of Jun 30, 2026
+7.7% YoY 10-Q filed Jul 29, 2026
Stockholders’ equity
$4.7B
As of Jun 30, 2026
+24.2% YoY 10-Q filed Jul 29, 2026
Shares outstanding
80.5M
As of Jul 24, 2026
-8.9% YoY 10-Q filed Jul 29, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $5.6B | +6.8% |
| Ended Mar 31, 2026 | $5.4B | +2.8% |
| Ended Sep 30, 2025 | $5.3B | +3.2% |
| Ended Jun 30, 2025 | $5.3B | +3.2% |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $21.3B | +3.1% |
| Ended Dec 31, 2024 | $20.7B | +0.5% |
| Ended Dec 31, 2023 | $20.6B | +7.2% |
| Ended Dec 31, 2022 | $19.2B | -1.6% |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$260.85
View live quote ↗
52-week low
$157.58
Jun 8, 2026
52-week high
$283.05
Aug 24, 2026
Below 52-week high
7.8%
1W return
+0.7%
1M return
-2.6%
3M return
+45.6%
6M return
+14.6%
YTD return
+31.3%
1Y return
+39.7%
30-day volatility
29.1%
90-day volatility
46.9%
1Y max drawdown
-34.1%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 28 filing(s) · 25 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Aug 31, 2026 observed Sep 4, 2026 filed · 4d Schedule 13G amendment | Reported reduction | 8.1M -307.7K | 10.00% +1.20 pts | $265.91 | $264.58 | $259.83 |
| T. Rowe Price Associates CIK0000080255 | Jun 30, 2026 observed Aug 14, 2026 filed · 45d Schedule 13G amendment | Reported accumulation | 8.0M +486.5K | 9.20% +1.40 pts | $187.08 | $267.90 | $259.83 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 3.9M | $259.83 |
Explore more institutional activity
Related research
Compare THC with other securities showing similar institutional activity or recent accumulation across several tracked institutions.